Bailard’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,635
| Closed | -$265K | – | 692 |
|
|
2022
Q1 | $265K | Hold |
1,635
| – | – | 0.01% | 581 |
|
|
2021
Q4 | $310K | Hold |
1,635
| – | – | 0.01% | 526 |
|
|
2021
Q3 | $330K | Hold |
1,635
| – | – | 0.01% | 503 |
|
|
2021
Q2 | $330K | Sell |
1,635
-135
| -8% | -$27.2K | 0.01% | 492 |
|
|
2021
Q1 | $311K | Hold |
1,770
| – | – | 0.01% | 503 |
|
|
2020
Q4 | $300K | Hold |
1,770
| – | – | 0.01% | 439 |
|
|
2020
Q3 | $287K | Buy |
1,770
+144
| +9% | +$23.3K | 0.01% | 394 |
|
|
2020
Q2 | $265K | Hold |
1,626
| – | – | 0.01% | 385 |
|
|
2020
Q1 | $208K | Hold |
1,626
| – | – | 0.01% | 400 |
|
|
2019
Q4 | $227K | Buy |
+1,626
| New | +$227K | 0.01% | 467 |
|
|
2019
Q3 | – | Sell |
-1,626
| Closed | -$210K | – | 533 |
|
|
2019
Q2 | $210K | Buy |
+1,626
| New | +$210K | 0.01% | 487 |
|
|
2019
Q1 | – | Sell |
-2,097
| Closed | -$233K | – | 543 |
|
|
2018
Q4 | $233K | Buy |
2,097
+272
| +15% | +$30.2K | 0.02% | 454 |
|
|
2018
Q3 | $249K | Hold |
1,825
| – | – | 0.01% | 488 |
|
|
2018
Q2 | $219K | Sell |
1,825
-135
| -7% | -$16.2K | 0.01% | 485 |
|
|
2018
Q1 | $236K | Sell |
1,960
-200
| -9% | -$24.1K | 0.02% | 439 |
|
|
2017
Q4 | $269K | Hold |
2,160
| – | – | 0.02% | 388 |
|
|
2017
Q3 | $290K | Buy |
2,160
+135
| +7% | +$18.1K | 0.02% | 250 |
|
|
2017
Q2 | $254K | Hold |
2,025
| – | – | 0.02% | 253 |
|
|
2017
Q1 | $241K | Hold |
2,025
| – | – | 0.02% | 263 |
|
|
2016
Q4 | $218K | Buy |
+2,025
| New | +$218K | 0.02% | 286 |
|